Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
63
MAN Quote, Financials, Valuation and Earnings
Last price:
$31.03
Seasonality move
:
3.14%
Day range:
$33.83 - $34.90
52-week range:
$26.14 - $63.35
Dividend yield:
4.19%
P/E ratio:
19.29x
P/S ratio:
0.09x
P/B ratio:
0.79x
Volume:
1.1M
Avg. volume:
1.2M
1-year change:
-38.3%
Market cap:
$1.6B
Revenue:
$18B
EPS (TTM):
-$0.29
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.7B | $19.8B | $18.9B | $17.9B | $18B | |
| Revenue Growth (YoY) | 15.13% | -4.33% | -4.61% | -5.61% | 0.58% | |
| Cost of Revenues | $17.3B | $16.3B | $15.6B | $14.8B | $15B | |
| Gross Profit | $3.4B | $3.6B | $3.4B | $3.1B | $3B | |
| Gross Profit Margin | 16.44% | 18.02% | 17.75% | 17.29% | 16.69% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.8B | $3B | $3.1B | $2.8B | $2.8B | |
| Other Inc / (Exp) | $9.5M | -$45.6M | -$59.5M | $7.5M | -- | |
| Operating Expenses | $2.8B | $2.9B | $2.9B | $2.7B | $2.8B | |
| Operating Income | $594.8M | $660.5M | $463.6M | $364.5M | $238.8M | |
| Net Interest Expenses | $38.8M | $46.9M | $79.7M | $90M | $95.4M | |
| EBT. Incl. Unusual Items | $568.1M | $557.1M | $205.9M | $256.8M | $93.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $185.7M | $183.3M | $117.1M | $111.7M | $106.7M | |
| Net Income to Company | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Basic EPS (Cont. Ops) | $7.02 | $7.16 | $1.78 | $3.04 | -$0.29 | |
| Diluted EPS (Cont. Ops) | $6.90 | $7.08 | $1.76 | $3.00 | -$0.29 | |
| Weighted Average Basic Share | $54.5M | $52.2M | $49.8M | $47.8M | $46.6M | |
| Weighted Average Diluted Share | $55.4M | $52.8M | $50.4M | $48.3M | $46.6M | |
| EBITDA | $668.2M | $745.1M | $552.2M | $451.1M | $324.8M | |
| EBIT | $594.8M | $660.5M | $463.6M | $364.5M | $238.8M | |
| Revenue (Reported) | $20.7B | $19.8B | $18.9B | $17.9B | $18B | |
| Operating Income (Reported) | $594.8M | $660.5M | $463.6M | $364.5M | $238.8M | |
| Operating Income (Adjusted) | $594.8M | $660.5M | $463.6M | $364.5M | $238.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.4B | $4.8B | $4.6B | $4.4B | $4.7B | |
| Revenue Growth (YoY) | 6.48% | -10.65% | -3.72% | -4.98% | 7.12% | |
| Cost of Revenues | $4.5B | $3.9B | $3.8B | $3.6B | $3.9B | |
| Gross Profit | $926.3M | $875.6M | $810.7M | $755.1M | $766.7M | |
| Gross Profit Margin | 17.21% | 18.21% | 17.51% | 17.16% | 16.27% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $759.7M | $774.8M | $850.2M | $686.9M | $686.1M | |
| Other Inc / (Exp) | $2.2M | -$36.7M | -$45.3M | $12.7M | -- | |
| Operating Expenses | $749.8M | $717.2M | $675.4M | $670.9M | $686.1M | |
| Operating Income | $176.5M | $158.4M | $135.3M | $84.2M | $80.6M | |
| Net Interest Expenses | $9.3M | $15.2M | $20M | $23M | $22.9M | |
| EBT. Incl. Unusual Items | $162.4M | $90.3M | -$55M | $47.7M | $65.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $51.3M | $41.6M | $29.5M | $25.2M | $35.4M | |
| Net Income to Company | $111.1M | $48.7M | -$84.5M | $22.5M | $30.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $111.1M | $48.7M | -$84.5M | $22.5M | $30.2M | |
| Basic EPS (Cont. Ops) | $2.05 | $0.96 | -$1.74 | $0.48 | $0.65 | |
| Diluted EPS (Cont. Ops) | $2.02 | $0.95 | -$1.74 | $0.47 | $0.65 | |
| Weighted Average Basic Share | $54.2M | $50.8M | $48.7M | $47.2M | -- | |
| Weighted Average Diluted Share | $55M | $51.4M | $48.7M | $47.7M | -- | |
| EBITDA | $199M | $179.1M | $159.6M | $106M | $101.1M | |
| EBIT | $176.5M | $158.4M | $135.3M | $84.2M | $80.6M | |
| Revenue (Reported) | $5.4B | $4.8B | $4.6B | $4.4B | $4.7B | |
| Operating Income (Reported) | $176.5M | $158.4M | $135.3M | $84.2M | $80.6M | |
| Operating Income (Adjusted) | $176.5M | $158.4M | $135.3M | $84.2M | $80.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20.7B | $19.8B | $18.9B | $17.9B | $18B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $17.3B | $16.3B | $15.6B | $14.8B | $15B | |
| Gross Profit | $3.4B | $3.6B | $3.4B | $3.1B | $3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.8B | $3B | $3.1B | $2.8B | $2.8B | |
| Other Inc / (Exp) | $9.5M | -$34.5M | -$53.3M | $20.3M | -- | |
| Operating Expenses | $2.8B | $2.9B | $2.9B | $2.7B | $2.7B | |
| Operating Income | $600.6M | $647.1M | $463.6M | $359.6M | $292.8M | |
| Net Interest Expenses | $38.8M | $46.9M | $79.7M | $90M | $95.4M | |
| EBT. Incl. Unusual Items | $568.1M | $557.1M | $205.9M | $256.8M | $93.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $185.7M | $183.3M | $117.1M | $111.7M | $106.7M | |
| Net Income to Company | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Basic EPS (Cont. Ops) | $7.02 | $7.14 | $1.70 | $3.03 | -$0.29 | |
| Diluted EPS (Cont. Ops) | $6.92 | $7.05 | $1.66 | $3.00 | -$0.29 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $674M | $731.7M | $552.2M | $446.2M | $378.8M | |
| EBIT | $600.6M | $647.1M | $463.6M | $359.6M | $292.8M | |
| Revenue (Reported) | $20.7B | $19.8B | $18.9B | $17.9B | $18B | |
| Operating Income (Reported) | $600.6M | $647.1M | $463.6M | $359.6M | $292.8M | |
| Operating Income (Adjusted) | $600.6M | $647.1M | $463.6M | $359.6M | $292.8M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.8B | $18.9B | $17.9B | $18B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $16.3B | $15.6B | $14.8B | $15B | -- | |
| Gross Profit | $3.6B | $3.4B | $3.1B | $3B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3B | $3.1B | $2.8B | $2.8B | -- | |
| Other Inc / (Exp) | -$34.5M | -$53.3M | $20.3M | -$83.3M | -- | |
| Operating Expenses | $2.9B | $2.9B | $2.7B | $2.7B | -- | |
| Operating Income | $647.1M | $463.6M | $359.6M | $292.8M | -- | |
| Net Interest Expenses | $46.9M | $79.7M | $90M | $95.4M | -- | |
| EBT. Incl. Unusual Items | $557.1M | $205.9M | $256.8M | $93.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $183.3M | $117.1M | $111.7M | $106.7M | -- | |
| Net Income to Company | $373.8M | $88.8M | $145.1M | -$13.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $373.8M | $88.8M | $145.1M | -$13.3M | -- | |
| Basic EPS (Cont. Ops) | $7.14 | $1.70 | $3.03 | -$0.29 | -- | |
| Diluted EPS (Cont. Ops) | $7.05 | $1.66 | $3.00 | -$0.29 | -- | |
| Weighted Average Basic Share | $208.8M | $199.3M | $191M | $139.8M | -- | |
| Weighted Average Diluted Share | $211.5M | $201.1M | $193.1M | $140.7M | -- | |
| EBITDA | $731.7M | $552.2M | $446.2M | $378.8M | -- | |
| EBIT | $647.1M | $463.6M | $359.6M | $292.8M | -- | |
| Revenue (Reported) | $19.8B | $18.9B | $17.9B | $18B | -- | |
| Operating Income (Reported) | $647.1M | $463.6M | $359.6M | $292.8M | -- | |
| Operating Income (Adjusted) | $647.1M | $463.6M | $359.6M | $292.8M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $5.4B | $5.1B | $4.8B | $4.3B | $4.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $126.7M | $158M | $160.8M | $163.7M | -- | |
| Total Current Assets | $6.4B | $5.9B | $5.6B | $5B | $5.8B | |
| Property Plant And Equipment | $490.2M | $477.9M | $543.9M | $479.7M | $515.9M | |
| Long-Term Investments | $114.2M | $95.8M | $102.2M | $103.9M | -- | |
| Goodwill | $1.7B | $1.6B | $1.6B | $1.6B | -- | |
| Other Intangibles | $583.6M | $549.5M | $519.6M | $486.1M | -- | |
| Other Long-Term Assets | $610.2M | $540.5M | $607.8M | $701.5M | -- | |
| Total Assets | $9.8B | $9.1B | $8.8B | $8.2B | $9.2B | |
| Accounts Payable | $3B | $2.8B | $2.7B | $2.6B | $2.7B | |
| Accrued Expenses | $584.7M | $572.6M | $693M | $573.7M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.8B | $4.9B | $4.8B | $4.4B | $5.2B | |
| Long-Term Debt | $841.5M | $1.2B | $1.3B | $1.2B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.3B | $6.7B | $6.6B | $6.1B | $7.1B | |
| Common Stock | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$389.4M | -$458.7M | -$466M | -$443M | -- | |
| Common Equity | $2.5B | $2.4B | $2.2B | $2.1B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $10M | $10.8M | $10.8M | $1.7M | $700K | |
| Total Equity | $2.5B | $2.5B | $2.2B | $2.1B | $2.1B | |
| Total Liabilities and Equity | $9.8B | $9.1B | $8.8B | $8.2B | $9.2B | |
| Cash and Short Terms | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Total Debt | $841.5M | $1.2B | $1.3B | $1.2B | $1.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $5.4B | $5.1B | $4.8B | $4.3B | $4.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $126.7M | $158M | $160.8M | $163.7M | -- | |
| Total Current Assets | $6.4B | $5.9B | $5.6B | $5B | $5.8B | |
| Property Plant And Equipment | $490.2M | $477.9M | $543.9M | $479.7M | $515.9M | |
| Long-Term Investments | $114.2M | $95.8M | $102.2M | $103.9M | -- | |
| Goodwill | $1.7B | $1.6B | $1.6B | $1.6B | -- | |
| Other Intangibles | $583.6M | $549.5M | $519.6M | $486.1M | -- | |
| Other Long-Term Assets | $610.2M | $540.5M | $607.8M | $701.5M | -- | |
| Total Assets | $9.8B | $9.1B | $8.8B | $8.2B | $9.2B | |
| Accounts Payable | $3B | $2.8B | $2.7B | $2.6B | $2.7B | |
| Accrued Expenses | $584.7M | $572.6M | $693M | $573.7M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.8B | $4.9B | $4.8B | $4.4B | $5.2B | |
| Long-Term Debt | $841.5M | $1.2B | $1.3B | $1.2B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.3B | $6.7B | $6.6B | $6.1B | $7.1B | |
| Common Stock | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | |
| Other Common Equity Adj | -$389.4M | -$458.7M | -$466M | -$443M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $10M | $10.8M | $10.8M | $1.7M | $700K | |
| Total Equity | $2.5B | $2.5B | $2.2B | $2.1B | $2.1B | |
| Total Liabilities and Equity | $9.8B | $9.1B | $8.8B | $8.2B | $9.2B | |
| Cash and Short Terms | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Total Debt | $841.5M | $1.2B | $1.3B | $1.2B | $1.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Depreciation & Amoritzation | $73.4M | $84.6M | $88.6M | $86.6M | $86M | |
| Stock-Based Compensation | $36.8M | $37.6M | $28.7M | $27.3M | $26.3M | |
| Change in Accounts Receivable | -$640.9M | $28.8M | $391.8M | $261.1M | -$142.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $644.8M | $423.3M | $348.2M | $309.2M | -$104.1M | |
| Capital Expenditures | $64.2M | $75.6M | $78.2M | $51.1M | $57.3M | |
| Cash Acquisitions | $925.6M | $17.5M | $600K | $19.7M | $3.1M | |
| Cash From Investing | -$988.2M | -$86.4M | -$74.7M | -$68.4M | -$59.2M | |
| Dividends Paid (Ex Special Dividend) | $136.6M | $139.9M | $144.3M | $145.8M | $66.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $75.5M | $421.3M | $1M | $3.7M | -- | |
| Long-Term Debt Repaid | -$2.2M | -$487.2M | -$4.4M | -$1.6M | -- | |
| Repurchase of Common Stock | $210M | $270M | $179.8M | $140M | $38.2M | |
| Other Financing Activities | -$7.5M | -$5.3M | -$600K | -$3M | -- | |
| Cash From Financing | -$282.5M | -$481M | -$348.9M | -$282.2M | $485.5M | |
| Beginning Cash (CF) | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$719.3M | -$208.8M | -$57.7M | -$71.9M | $361.6M | |
| Ending Cash (CF) | $35.1M | $365.5M | $541.3M | $407M | $1.3B | |
| Levered Free Cash Flow | $580.6M | $347.7M | $270M | $258.1M | -$161.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $111.1M | $48.7M | -$84.5M | $22.5M | $30.2M | |
| Depreciation & Amoritzation | $22.5M | $20.7M | $24.3M | $21.8M | $20.5M | |
| Stock-Based Compensation | $10.1M | $8.4M | $8.7M | $5.3M | $6.1M | |
| Change in Accounts Receivable | -$286.9M | -$167.1M | -$68.4M | $23.3M | -$133.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $261.9M | $134.1M | $113.7M | $247.6M | $178.9M | |
| Capital Expenditures | $24.5M | $19.7M | $23.1M | $11.3M | $10.9M | |
| Cash Acquisitions | $917.3M | $100K | -- | $14.6M | -- | |
| Cash From Investing | -$942.4M | -$20.1M | -$21.6M | -$26.3M | -$10.5M | |
| Dividends Paid (Ex Special Dividend) | $68.3M | $68.7M | $71.2M | $72.3M | $33.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $75.1M | $200K | $300K | $3.1M | -- | |
| Long-Term Debt Repaid | -- | $1.4M | -$3.7M | -$400K | -- | |
| Repurchase of Common Stock | $59.9M | $25M | $50M | $34M | -- | |
| Other Financing Activities | -$100K | -$2.2M | -- | -- | -- | |
| Cash From Financing | -$56.9M | -$87.2M | -$123.2M | -$103.4M | $426M | |
| Beginning Cash (CF) | $847.8M | $639M | $581.3M | $509.4M | $871M | |
| Foreign Exchange Rate Adjustment | -$27.4M | $84.7M | $41.9M | -$19.2M | $2M | |
| Additions / Reductions | -$764.8M | $111.5M | $10.2M | $98.5M | $596.4M | |
| Ending Cash (CF) | $55.6M | $835.2M | $633.4M | $588.7M | $1.5B | |
| Levered Free Cash Flow | $237.4M | $114.4M | $90.6M | $236.3M | $168M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $382.4M | $373.8M | $88.8M | $145.1M | -$13.3M | |
| Depreciation & Amoritzation | $73.4M | $84.6M | $88.6M | $86.6M | $86M | |
| Stock-Based Compensation | $36.8M | $37.6M | $28.7M | $27.3M | $26.3M | |
| Change in Accounts Receivable | -$640.9M | $28.8M | $391.8M | $261.1M | -$142.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $644.8M | $423.3M | $348.2M | $309.2M | -$104.1M | |
| Capital Expenditures | $64.2M | $75.6M | $78.2M | $51.1M | $57.3M | |
| Cash Acquisitions | $925.6M | $17.5M | $600K | $19.7M | $3.1M | |
| Cash From Investing | -$988.2M | -$86.4M | -$74.7M | -$68.4M | -$59.2M | |
| Dividends Paid (Ex Special Dividend) | $136.6M | $139.9M | $144.3M | $145.8M | $66.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $75.5M | $421.3M | $1M | $3.7M | -- | |
| Long-Term Debt Repaid | -$2.2M | -$487.2M | -$4.4M | -$1.6M | -- | |
| Repurchase of Common Stock | $210M | $270M | $179.8M | $140M | $38.2M | |
| Other Financing Activities | -$7.5M | -- | -- | -$3M | -- | |
| Cash From Financing | -$282.5M | -$481M | -$348.9M | -$282.2M | $485.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$719.3M | -$208.8M | -$57.7M | -$71.9M | $361.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $580.6M | $347.7M | $270M | $258.1M | -$161.4M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $373.8M | $88.8M | $145.1M | -$13.3M | -- | |
| Depreciation & Amoritzation | $84.6M | $88.6M | $86.6M | $86M | -- | |
| Stock-Based Compensation | $37.6M | $28.7M | $27.3M | $26.3M | -- | |
| Change in Accounts Receivable | $28.8M | $391.8M | $261.1M | -$142.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $423.3M | $348.2M | $309.2M | -$104.1M | -- | |
| Capital Expenditures | $75.6M | $78.2M | $51.1M | $57.3M | -- | |
| Cash Acquisitions | $17.5M | $600K | $19.7M | $3.1M | -- | |
| Cash From Investing | -$86.4M | -$74.7M | -$68.4M | -$59.2M | -- | |
| Dividends Paid (Ex Special Dividend) | $139.9M | $144.3M | $145.8M | $66.7M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $421.3M | $1000K | $3.7M | $136.1M | -- | |
| Long-Term Debt Repaid | -$487.2M | -$4.4M | -$1.6M | -$400K | -- | |
| Repurchase of Common Stock | $270M | $179.8M | $140M | $38.2M | -- | |
| Other Financing Activities | -$5.3M | -$600K | -$3M | -$1.3M | -- | |
| Cash From Financing | -$481M | -$348.9M | -$282.2M | $485.5M | -- | |
| Beginning Cash (CF) | $2.8B | $2.3B | $2B | $1.8B | -- | |
| Foreign Exchange Rate Adjustment | -$64.7M | $17.7M | -$30.5M | $39.4M | -- | |
| Additions / Reductions | -$208.8M | -$57.7M | -$71.9M | $361.6M | -- | |
| Ending Cash (CF) | $2.6B | $2.2B | $1.9B | $2.2B | -- | |
| Levered Free Cash Flow | $347.7M | $270M | $258.1M | -$161.4M | -- | |
Get MAN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MAN
Sector
P/E ratio
19.29x
20.33x
PEG ratio
0.14x
0.18x
P/B ratio
0.79x
1.80x
Price / LTM sales
0.09x
0.89x
Growth Metrics
MAN
Sector
Revenue growth
7.12%
4.57%
Earnings growth
37.35%
3.54%
Revenue (5-year growth)
-0.05%
4.49%
Earnings forecast
$0.82
$0.33
Profitability
MAN
Sector
Profitability FY 2025
$3B
$238.5M
Return on invested capital
-0.36%
4.52%
Return on assets
-0.16%
3.09%
Return on equity
-0.65%
7.99%
Earnings Date
Last Earnings Date
Jan
29
Next Earnings Date
Apr
16
Estimated Next Earnings Date
Apr
30
Balance Sheet
MAN
Sector
Total cash
$871M
$138.4M
Short term investments
--
$31.1M
Total assets
$9.2B
$1.4B
Long term debt
$1.4B
$44.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 18.79% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 5.08% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 5.06% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
